Targacept Revenue and Competitors
Estimated Revenue & Valuation
- Targacept's estimated annual revenue is currently $5.7M per year.
- Targacept's estimated revenue per employee is $155,000
Employee Data
- Targacept has 37 Employees.
- Targacept grew their employee count by 0% last year.
Targacept's People
| Name | Title | Email/Phone |
|---|
Targacept Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Targacept?
Targacept is developing a diverse pipeline of innovative NNR Therapeuticsâ„¢ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that are impaired in various disease states. Targacept's clinical pipeline includes multiple Phase 2 product candidates, all representing first-in-class opportunities. Targacept leverages its scientific leadership and diverse pipeline to attract significant collaborations with global pharmaceutical companies. For more information, please visit www.targacept.com.
keywords:N/A
N/A
Total Funding
37
Number of Employees
$5.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Winston-Salem
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.8M | 37 | -44% | N/A |
#2 | N/A | 37 | 118% | N/A |
#3 | $8M | 37 | 0% | N/A |
#4 | $8.2M | 38 | 9% | N/A |
#5 | $7.5M | 38 | 3% | N/A |